Virtu Financial’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,421
Closed -$16K 1332
2024
Q4
$16K Buy
+10,421
New +$14.6K ﹤0.01% 1329
2022
Q4
Sell
-11,536
Closed -$52K 1575
2022
Q3
$52K Buy
+11,536
New +$82.6K ﹤0.01% 1193
2021
Q4
Sell
-10,784
Closed -$149K 1683
2021
Q3
$149K Buy
+10,784
New +$113K 0.01% 1011
2018
Q4
Sell
-20,895
Closed -$148K 1532
2018
Q3
$148K Buy
+20,895
New +$116K 0.01% 1137
2018
Q2
Sell
-14,531
Closed -$43K 1958
2018
Q1
$43K Sell
14,531
-3,295
-18% -$8.48K ﹤0.01% 1737
2017
Q4
$46K Buy
+17,826
New +$55.6K ﹤0.01% 2089

Other funds holding APYX

Virtu Financial's APYX Position: Q1 2025 in Review

Virtu Financial sold out of Apyx Medical (APYX) in Q1 2025, closing a stake of 10,421 shares — an estimated $16K sold.

Virtu Financial first reported a position in APYX in Q4 2017 and held it in 6 quarters. The position peaked at $149K in Q3 2021. 43 funds tracked by Wall St. Rank hold APYX as of Q1 2025.

  • Virtu Financial reported no remaining Apyx Medical position as of Q1 2025 after selling out during the quarter.
  • Virtu Financial sold 10,421 Apyx Medical shares in Q1 2025, an estimated $16K.
  • Virtu Financial first reported a position in Apyx Medical in Q4 2017 and held it in 6 quarters.
  • Virtu Financial's Apyx Medical position peaked at $149K in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2025.

Based on Virtu Financial's 13F filing for Q1 2025, filed 12 May 2025.